Jul 8, 2013 - Blog by Ingrid Evans | Share
ATTORNEY NEWSLETTER In the past, the Food and Drug Administration (FDA) took the lead role in investigating pharmaceutical manufacturing facilities for violations of good manufacturing practices (cGMP’s). Recently, the Department of Justice (DOJ) became a more actively involved in enforcement actions against pharmaceutical manufacturing facilities due to whistleblowers. The DOJ […]